Kero J, Koskenniemi JJ, Karsikas S, Pokka T, et al. INnoVative trial design for testing the Efficacy, Safety, and Tolerability of 6-month treatment with incretin-based therapy to prevent type 1 DIAbetes in autoantibody positive participants: a protocol for three parallel double-blind randomised control Diabet Med 2022 Jul 7:e14913. doi: 10.1111/dme.14913.
PMID: 35797241